| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.09 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.083 | 0.09 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.27 | 0.09 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.09 |